comparemela.com

Latest Breaking News On - Nyseamerican cvm - Page 1 : comparemela.com

CEL-SCI (NYSEAMERICAN:CVM) Upgraded to Hold at StockNews.com

StockNews.com upgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Free Report) from a sell rating to a hold rating in a research report released on Tuesday. Separately, EF Hutton Acquisition Co. I restated a buy rating and issued a $10.00 price objective on shares of CEL-SCI in a report on Thursday, March 9th. CEL-SCI Price Performance Shares […]

Nations-financial-group-inc
Company-profile
Ef-hutton-acquisition-co
Investors-services
Free-report
Sigma-investments
Nations-financial-group
Leukocyte-interleukin
Cel-sci
Nyseamerican-cvm
Icvm

CEL-SCI (NYSEAMERICAN:CVM) Shares Pass Below 50 Day Moving Average of $2.39

CEL-SCI Co. (NYSEAMERICAN:CVM – Free Report)’s stock price crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $2.39 and traded as low as $2.35. CEL-SCI shares last traded at $2.44, with a volume of 108,333 shares. Analysts Set New Price Targets Separately, StockNews.com […]

Diamond-financial
Nations-financial-group-inc
Cutter-co-brokerage-inc
Threadgill-financial
Free-report
Financial-group
Leukocyte-interleukin
Cel-sci
Nyseamerican-cvm
Icvm
Medical

CEL-SCI (NYSEAMERICAN:CVM) Stock Passes Below 50 Day Moving Average of $2.39

Shares of CEL-SCI Co. (NYSEAMERICAN:CVM – Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $2.39 and traded as low as $2.35. CEL-SCI shares last traded at $2.44, with a volume of 108,333 shares changing hands. Wall Street Analyst Weigh In […]

Switzerland
Swiss
Swiss-national-bank
Renaissance-technologies
Goldman-sachs-group-inc
Company-profile
Dimensional-fund-advisors
Topco-ltd
Free-report
National-bank
Fund-advisors

CEL-SCI (NYSEAMERICAN:CVM) Upgraded by StockNews.com to "Hold"

StockNews.com upgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Free Report) from a sell rating to a hold rating in a research report released on Sunday. Separately, EF Hutton Acquisition Co. I reissued a buy rating and set a $10.00 price target on shares of CEL-SCI in a research note on Thursday, March 9th. CEL-SCI Price Performance […]

Geode-capital-management
Renaissance-technologies
A-davidson
Vanguard-group-inc
Ef-hutton-acquisition-co
Millennium-management
Free-report
Capital-management
Leukocyte-interleukin
Cel-sci
Nyseamerican-cvm

CEL-SCI (NYSEAMERICAN:CVM) Upgraded to "Hold" at StockNews.com

StockNews.com upgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Free Report) from a sell rating to a hold rating in a report released on Saturday morning. Separately, EF Hutton Acquisition Co. I reaffirmed a buy rating and set a $10.00 price objective on shares of CEL-SCI in a research report on Thursday, March 9th. CEL-SCI Price Performance […]

Switzerland
Swiss
Goldman-sachs-group-inc
Renaissance-technologies
Swiss-national-bank
Ef-hutton-acquisition-co
Dimensional-fund-advisors
Company-profile
Topco-ltd
Free-report
National-bank

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.